[Chemoprevention of hepatocellular carcinoma by acyclic retinoid].
Nagaki
Masahito
M
Department of Gastroenterology, Gifu University Graduate School of Medicine.
Shimizu
Masahito
M
Moriwaki
Hisataka
H
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D008113:Liver Neoplasms / Q000209:etiology / Q000517:prevention & control*; D009364:Neoplasm Recurrence, Local / Q000209:etiology / Q000517:prevention & control*; D018168:Receptors, Retinoic Acid / Q000502:physiology; D047488:Retinoid X Receptors / Q000502:physiology; D014212:Tretinoin / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000970:Antineoplastic Agents; D018168:Receptors, Retinoic Acid; D047488:Retinoid X Receptors; D014212:Tretinoin; C034534:3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid